PTPRC and neoplasm: To obtain a full picture of TIOs-induced immunological changes in the tumours, CD45+ leucocytes from 4T1 tumour-bearing PBS-treated and TIOs+NIR3-treated mice were subjected to single-cell RNA sequencing (scRNA-Seq) analyses.